Cargando…
Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP(1))-mediated Pathway
BACKGROUND/AIMS: Lubiprostone, a chloride channel type 2 (ClC-2) activator, was thought to treat constipation by enhancing intestinal secretion. It has been associated with increased intestinal transit and delayed gastric emptying. Structurally similar to prostones with up to 54% prostaglandin E(2)...
Autores principales: | Chan, Walter W, Mashimo, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714408/ https://www.ncbi.nlm.nih.gov/pubmed/23875097 http://dx.doi.org/10.5056/jnm.2013.19.3.312 |
Ejemplares similares
-
Lubiprostone stimulates small intestinal mucin release
por: De Lisle, Robert C
Publicado: (2012) -
Smooth muscle NOS, colocalized with caveolin-1, modulates contraction in mouse small intestine
por: El-Yazbi, Ahmed F, et al.
Publicado: (2008) -
Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
por: De Lisle, Robert C, et al.
Publicado: (2010) -
Ca(2+) signals evoked by histamine H(1) receptors are attenuated by activation of prostaglandin EP(2) and EP(4) receptors in human aortic smooth muscle cells
por: Pantazaka, Evangelia, et al.
Publicado: (2013) -
Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)